BiotechTube

Reldesemtiv

Phase 3Terminated
0 watching 0 views this week📈 Rising
74
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Amyotrophic Lateral Sclerosis

Conditions

Amyotrophic Lateral Sclerosis

Trial Timeline

Aug 4, 2022 → Jun 7, 2023

NCT ID
NCT05442775

About Reldesemtiv

Reldesemtiv is a phase 3 stage product being developed by Cytokinetics for Amyotrophic Lateral Sclerosis. The current trial status is terminated. This product is registered under clinical trial identifier NCT05442775. Target conditions include Amyotrophic Lateral Sclerosis.

Hype Score Breakdown

Clinical
27
Activity
18
Company
7
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT05442775Phase 3Terminated

Competing Products

20 competing products in Amyotrophic Lateral Sclerosis

See all competitors
ProductCompanyStageHype Score
AL001 + PlaceboAlectorPhase 2
44
89Zr-DFO-AP-101Eli LillyPhase 1
33
Reldesemtiv + PlaceboAstellas PharmaPhase 2
52
Perampanel + Placebo Oral TabletEisaiPre-clinical
23
E0302 (mecobalamin)EisaiPhase 2/3
65
E0302 (mecobalamin) + E0302 (mecobalamin) + PlaceboEisaiPhase 2/3
65
methylcobalamin + saline solutionEisaiPhase 3
77
ONO-2506POOno PharmaceuticalPhase 2
52
ONO-2506PO + ONO-2506POOno PharmaceuticalPhase 2
52
ZYIL1 capsules 25 mg and 50 mg Placebo + ZYIL1 capsules 50 mg and 25 mg Placebo + ZYIL1 capsules 25 mg and ZYIL1 capsules 50 mg + Matching placebo 25 mg and Matching placebo 50 mgZydus LifesciencesPhase 2
52
LY4256984 + PlaceboEli LillyPhase 1
33
TCH346NovartisPhase 2
52
VHB937NovartisPhase 2
52
TCH346NovartisPhase 2
52
TCH346NovartisPhase 2
52
BLZ945NovartisPhase 2
52
TRO19622RochePhase 2/3
65
Olesoxime + Placebo Comparator + RiluzoleRochePhase 3
77
Bosutinib (Phase 1 part) + Bosutinib (Phase 2 part)PfizerPhase 1/2
40
Celecoxib + Creatine + MinocyclinePfizerPhase 2
51

Other Products from Cytokinetics

Tirasemtiv + Placebo tabletsPhase 3
74
Aficamten (5 mg, 10 mg, 15 mg, and 20 mg) + Placebo to match aficamtenPhase 3
74
Omecamtiv Mecarbil (OM) + PlaceboPhase 3
74
Omecamtiv mecarbilPhase 3
74
Omecamtiv Mecarbil + PlaceboPhase 3
74